Medileap Technologies Private Limited - Due diligence report

A 360° intelligence report on Medileap Technologies Private Limited: trust score, financial health, credit view, compliance, directors, grow…

2015-08-21 Surat, Gujarat Strike Off Unlisted Active Compliant
Share
Connect MCP
MT Medileap Technologies Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Medileap Technologies Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
48/100
Trust Score
Caution Indicated

Medileap Technologies Private Limited is assessed as Caution Indicated with a Trust Score of 48/100. Medileap Technologies Private Limited is a private limited indian non-government company incorporated in 2015, operating in the Healthcare sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 09 Aug 2026 from the latest processed filings. Medileap Technologies Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
48/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
30/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
25/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
35/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 30/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Last balance sheet is for Mar 2021 - filings overdue.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SIMI SAMEER BATRA 01234567 Director 01/04/2018 6 yrs Approved
SUBIR ATAMPARKASH BATRA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 5 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 35
Growth signals & trust indicators
Latest year revenue grew 38%.
Operating for 10+ years.
Distress signals & risk flags
Negative net worth.
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (30/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence37/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment35/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view45/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
30 Nov 2021
Last AGM held
Annual general meeting
31 Mar 2021
Latest balance sheet
Filed with ROC
31 Mar 2017
Share transfer (FY 2017)
5000 shares to PRASHANT
Share transfer (FY 2017)
500 shares to NEHA
Share transfer (FY 2017)
1000 shares to SIVARAM
Share transfer (FY 2017)
10000 shares to SATYANAND AKHILESH
Share transfer (FY 2017)
3800 shares to ATAMPARKASH SUBIR
09 Mar 2017
Director ceased
ALPESHKUMAR DHIRAJLAL PATEL
28 Feb 2017
Director appointed
SIMI SAMEER BATRA (Director)
28 Apr 2016
Securities allotted
129227 Equity Shares Without Differential Rights - 12.92 Lakh raised
10 Feb 2016
Securities allotted
64200 Equity Shares Without Differential Rights - 6.42 Lakh raised
21 Aug 2015
Incorporated
Registered with Roc Ahmedabad
Director appointed
SUBIR ATAMPARKASH BATRA (Director)
10

Key Observations

Auto-generated from the data above
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2019 annual return.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Waraha Enterprises Private Limited U74999TG2008PTC058426 Khairatabad, Telangana, India
Helious Pharma Private Limited U51909DL2017PTC319211 Delhi, Delhi, India
Fusion Commotrade Private Limited U52100WB2010PTC143729 Howrah, West Bengal, India
Wireless Exim Private Limited U52190RJ2002PTC017745 Na, Rajasthan, India
Kristol Exim Private Limited U19201UP2004PTC029265 Kanpur, Uttar Pradesh, India
Aeyon Foods Private Limited U15132DL2015PTC285755 Naya Bazar, Delhi, India
Yamini India Private Limited U52300MH2014PTC256300 Mumbai, Maharashtra, India
Blythe Tradecon Private Limited U51109CT2007PTC001234 Bilaspur, Chattisgarh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Medileap Technologies Private Limited before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Medileap Technologies Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Medileap Technologies Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 48/100, distress signals and MSME payment-delay disclosures - know whether Medileap Technologies Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Medileap Technologies Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Medileap Technologies Private Limited an active company?

Medileap Technologies Private Limited has MCA status “Strike Off” with a compliance score of 30/100 (Caution Indicated).

Is Medileap Technologies Private Limited financially healthy?

Medileap Technologies Private Limited has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Medileap Technologies Private Limited?

Its overall Trust Score is 48/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Medileap Technologies Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Medileap Technologies Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Medileap Technologies Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2021 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).

Is it risky to lend to Medileap Technologies Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.